Thyroid dysfunction in obese pre-pubertal children: Oxidative stress as a potential pathogenetic mechanism

References

• Cali AM, Caprio S. Obesity in children and adolescents. J Clin Endocrinol Metab 2008;93:31–36.
   PubMed Web of Science ®Google Scholar
• Nathan BM, Moran A. Metabolic complications of obesity in childhood and adolescence: more than just diabetes. Curr Opin Endocrinol Diabetes Obes 2008;15:21–29.
   Google Scholar
• Reinehr T. Obesity and thyroid function. Mol Cell Endocrinol 2010;316:165–171.
   PubMed Web of Science ®Google Scholar
• Nader NS, Bahn RS, Johnson MD, Weaver AL, Singh R, Kumar S. Relationships between thyroid function and lipid status or insulin resistance in a pediatric population. Thyroid 2010;20:1333–1339.
   Google Scholar
• Bhowmick SK, Dasari G, Levens KL, Rettig KR. The prevalence of elevated serum thyroid-stimulating hormone in childhood/adolescent obesity and of autoimmune thyroid diseases in a subgroup. J Natl Med Assoc 2007;99:773–776.
   Google Scholar
• Stichel H, l'Allemand D, Gruters A. Thyroid function and obesity in children and adolescents. Horm Res 2000;54: 14–19.
   PubMedGoogle Scholar
• Shalitin S, Yackobovitch-Gavan M, Phillip M. Prevalence of thyroid dysfunction in obese children and adolescents before and after weight reduction and its relation to other metabolic parameters. Horm Res 2009;71:155–161.
   PubMed Web of Science ®Google Scholar
• Reinher T, de Sousa G, Andler W. Hyperthyrotropinemia in obese children is reversible after weight loss and is not related to lipids. J Clin Endocrinol Metab 2006;91:3088–3091.
   Google Scholar
• Marras V, Casini MR, Pilia S, Carta D, Civolani P, Porcu M, . Thyroid function in obese children and adolescents. Horm Res Paediatr 2010;73:193–197.
   Google Scholar
• Zimmermann MB, Aeberli I, Melse-Boonstra A, Grimci L, Bridson J, Chaouki N, . Iodine treatment in children with subclinical hypothyroidism due to chronic iodine deficiency decreases thyrotropin and C-peptide concentrations and improves the lipid profile. Thyroid 2009;19:1099–1104.
   Google Scholar
• Baskol G, Atmaca H, Tanriverdi F, Baskol M, Kocer D, Bayram F. Oxidative stress and enzymatic antioxidant status in patients with hypothyroidism before and after treatment. Exp Clin Endocrinol Diabetes 2007;115:522–526.
   PubMed Web of Science ®Google Scholar
• Erdamar H, Demirci H, Yaman H, Erbil MK, Yakar T, Sancak B, . The effect of hypothyroidism, hyperthyroidism, and their treatment on parameters of oxidative stress and antioxidant status. Clin Chem Lab Med 2008;46:1004–1010.
   PubMed Web of Science ®Google Scholar
• Santi A, Duarte MM, Moresco RN, Menezes C, Bagarini MD, Schetinger MR, Loro VL. Association between thyroid hormones, lipids and oxidative stress biomarkers in overt hypothyroidism. Clin Chem Lab Med 2010;48:1635–1639.
   PubMed Web of Science ®Google Scholar
• Torun AN, Kulaksizoglu S, Kulaksizoglu M, Pamuk BO, Isbilen E, Tutuncu NB. Serum total antioxidant status and lipid peroxidation marker malondialdehyde levels in overt and subclinical hypothyroidism. Clin Endocrinol (Oxf) 2009;70:469–474.
   PubMed Web of Science ®Google Scholar
• Oge A, Sozmen E, Karaoglu AO. Effect of thyroid function on LDL oxidation in hypothyroidism and hyperthyroidism. Endocr Res 2004;30:481–489.
   PubMed Web of Science ®Google Scholar
• Giannini C, de Giorgis T, Scarinci A, Cimapani M, Marcovecchio ML, Chiarelli F, Mohn A. Obese related effects of inflammatory markers and insulin resistance on increased carotid intima media thickness in pre-pubertal children. Atherosclerosis 2008;197:448–456.
   PubMed Web of Science ®Google Scholar
• Mohn A, Catino M, Capanna R, Giannini C, Marcovecchio M, Chiarelli F. Increased oxidative stress in prepubertal severely obese children: effect of a dietary restriction-weight loss program. J Clin Endocrinol Metab 2005;90:2653–2658.
   PubMed Web of Science ®Google Scholar
• Krebs NF, Jacobson MS. American Academy of Pediatrics, Committee on Nutrition. Prevention of pediatric overweight and obesity. Pediatrics 2003;112:424–430.
   PubMed Web of Science ®Google Scholar
• Rolland-Cachera MF, Cole TJ, Sempè M, Tichet J, Rossignol C, Charraud A. Body mass index variations: centiles from birth to 87 y. Eur J Clin Nutr 1991;45:13–21.
   PubMed Web of Science ®Google Scholar
• Heinze E, Holl RW. Test of β-cell function in childhood and adolescence. In: Ranke MB, ed. Diagnostics of Endocrine Function in Children and Adolescents. Switzerland: Karger Basel; 2003. p 318–388.
   Google Scholar
• Yeckel CW, Weiss R, Dziura J, Taksali SE, Dufour S, Burgert TS, . Validation of insulin sensitivity indices from oral glucose tolerance test parameters in obese children and adolescents. J Clin Endocrinol Metab 2004;89:1096–1110.
   PubMed Web of Science ®Google Scholar
• Tremblay AJ, Morrissette H, Gagné JM, Bergeron J, Gagnè C, Couture P. Validation of the Friedewald formula for the determination of low-density lipoprotein cholesterol compared with beta-quantification in a large population. Clin Biochem 2004;37:785–790.
   PubMed Web of Science ®Google Scholar
• Roberts LJ, Morrow JD. Measurement of F2-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 2000;28:505–513.
   PubMed Web of Science ®Google Scholar
• Grandone A, Santoro N, Coppola F, Calabrò P, Perrone L, Del Giudice EM. Thyroid function derangement and childhood obesity: an Italian experience. BMC Endocr Disord 2010;10:1–7.
   Google Scholar
• Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, . Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004;114:1752–1761.
   PubMed Web of Science ®Google Scholar
• Keaney J, Larson M, Vasan R, Wilson PW, Lipinska I, Corey D, . Framingham Study. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol 2003;23:434–439.
   PubMed Web of Science ®Google Scholar
• Patrono C, FitzGerald GA. Isoprostanes: potential markers of oxidant stress in atherothrombotic disease. Arterioscler Thromb Vasc Biol 1997;17:2309–2315.
   PubMed Web of Science ®Google Scholar
• Koyama H, Yokoyama H, Motoyama K, Mori K, Fukumoto S, Emoto M, . Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol 2005;25:2587–2593.
   PubMed Web of Science ®Google Scholar
• Giannini C, D'Adamo E, de Giorgis T, Chiavaroli V, Verrotti A, Chiarelli F, Mohn A. The possible role of esRAGE and sRAGE in the natural history of diabetic nephropathy in childhood. Pediatr Nephrol 2012;27:269–275.
   Google Scholar
• D'Adamo E, Giannini C, Chiavaroli V, de Girogis T, Verrotti A, Chiarelli F, Mohn A. What is the significance of soluble and endogenous secretory receptor for advanced glycation end products in liver steatosis in obese prepubertal children? Antioxid Redox Signal 2011;14:1167–1172.
   PubMed Web of Science ®Google Scholar
• Poncin S, Van Eeckoudt S, Humblet K, Colin IM, Gèrard AC. Oxidative stress: a required condition for thyroid cell proliferation. Am J Pathol 2010;176:1355–1363.
   PubMed Web of Science ®Google Scholar
• Nadolnik LI, Niatsetskaya ZV, Lupachyk SV. Effect of oxidative stress on rat thyrocyte iodide metabolism. Cell Biochem Funct 2008;26:366–373.
   Google Scholar
• Konukoglu D, Ercan M, Hatemi H. Plasma viscosity in female patients with hypothyroidism: effects of oxidative stress and cholesterol. Clin Hemorheol Microcirc 2002;27:107–113.
   PubMed Web of Science ®Google Scholar